Free Aspire

November 3, 2020

EFA® and Parkinson’s Disease

The EFA® technology in Parkinson’s patients with dysphagia Parkinson’s disease (PD) can cause swallowing and cough disorders. Oropharyngeal dysphagia is the main cause of pneumonia, that […]
December 10, 2019

EFA® versus PEP

Rehabilitation protocols in COPD patients Two clinical trials, comparing EFA® technology with PEP exercises, both in association with a pulmonary rehabilitation program, have been published. Airway […]
October 14, 2019

EFA® in tracheostomised patients

A recent study shows that EFA® technology is a suitable support for the non-invasive management of pulmonary secretions in tracheostomised patients. Published on the Clinical Respiratory […]
May 29, 2019
EFA technology in pediatrics

EFA® technology in paediatrics

A pilot study investigates the effectiveness of the Free Aspire device in the management of bronchial secretions and highlights its positive response in paediatrics patients with […]